Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00847730 · ClinicalTrials.gov registry record · NA
Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy
A NA study of Diabetic Foot Ulcers, sponsored by KCI USA.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 6
- Study locations
NCT00847730: Completed NA study of Diabetic Foot Ulcers, sponsored by KCI USA.
NCT00847730 is a NA study of Diabetic Foot Ulcers that has completed, run by KCI USA. The registered enrollment target is 33 participants, below the 232-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (86% lower). The trial reports 6 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00847730, a NA study of Diabetic Foot Ulcers, has completed, sponsored by KCI USA.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 6
- Study locations
Study Summary
The study is aimed at evaluating the clinician's perceived ease of using the V.A.C. GranuForm bride dressing and the patients perceived level of comfort during the dressing wear.
Primary Outcome
Each subject was assessed on the three scales (each scale was 1-Poor, 2 - Fair, 3 - Good, 4 - Excellent) and given a score on each individual characteristic (Ease of Dressing Application, Ease of Conformability, and Ease of Dressing Removal). The scores were then summed for each subject with possible range being 3-12. If the subject had a total score greater than or equal to 6, and a minimum score of greater than or equal to 2 on each individual characteristic then the subject was included in th
Conditions Studied
Interventions
- DEVICE V.A.C. Negative Pressure Wound Therapy System
Study Locations (6)
Texas
- Alamo Clinical Research Consultants - San Antonio
- Alamo Family Foot and Ankle Care - San Antonio
- Scott and White Dept of Surgery - Temple
Connecticut
- North American Center for Limb Preservation - New Haven
Florida
- Drs Research Network - South Miami
Pennsylvania
- Key Stone Medical Research Associates - Bethlehem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-02 |
| Est. Completion | 2009-09 |
| Phase | NA |
What the finished NCT00847730 record still lists
NCT00847730 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 232-participant average among 12 other Diabetic Foot Ulcers trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Diabetic Foot Ulcers appearing as the primary indexed condition, and to 1 intervention - of which V.A.C. Negative Pressure Wound Therapy System is the first listed.
NCT00847730 lists 6 locations in 4 states (Texas, Connecticut, Florida).
Frequently Asked Questions
What is clinical trial NCT00847730 about?
NCT00847730 is a clinical study titled "Evaluating the Ease of Use of a VAC GranuFoam Bridge Dressing on Diabetic Foot Ulcers Receiving VAC Negative Pressure Wound Therapy". The study is aimed at evaluating the clinician's perceived ease of using the V.A.C. GranuForm bride dressing and the patients perceived level of comfort during the dressing wear.
What is the current status of trial NCT00847730?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-02. Estimated completion is 2009-09.
What conditions does trial NCT00847730 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcers.
What interventions are being tested in trial NCT00847730?
The interventions under investigation include: V.A.C. Negative Pressure Wound Therapy System (DEVICE).
Who is sponsoring clinical trial NCT00847730?
This trial is sponsored by KCI USA, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00847730 being conducted?
This trial has 6 study locations across Connecticut, Florida, Pennsylvania, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00847730's enrollment target sits among peer trials
33 12th of 12 higher than 1 of 12 other Diabetic Foot Ulcers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot Ulcers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Instant Total Contact Cast to Heal Diabetic Foot Ulcers
COMPLETED · NA
-
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
ACTIVE NOT RECRUITING · Phase 2
-
Wound Healing Endpoint and Recurrence
ACTIVE NOT RECRUITING · Phase 1
-
Clinical Trials of Footwear in Patients With Diabetes-Study Arm 2,3
COMPLETED · Phase 2
-
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
COMPLETED
-
Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia